FDA Approves Merck Drug for Dog Screwworm
The US FDA granted emergency use authorization for Mercks Bravecto tablets to treat New World screwworm infestations in dogs and puppies. The prescription treatment aims to combat the parasite in affected regions while monitoring for potential neurological risks.
Merck received an emergency use authorization from the United States Food and Drug Administration on Tuesday evening for Bravecto tablets to treat New World screwworm in dogs. The authorization expands available treatment options to combat the parasite during public health threats. Dog owners in affected regions face heightened monitoring requirements as authorities work to contain the infestation.
